Shares of First Advantage Co. (NYSE:FA – Get Free Report) have received an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $58.67.
Several equities analysts recently issued reports on the company. Royal Bank of Canada restated an “outperform” rating and set a $22.00 price objective on shares of First Advantage in a research note on Thursday, January 23rd. Barclays reduced their price target on shares of First Advantage from $22.00 to $20.00 and set an “overweight” rating on the stock in a research report on Friday, February 28th. BMO Capital Markets lowered their price objective on shares of First Advantage from $24.00 to $22.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Finally, William Blair reiterated an “outperform” rating on shares of First Advantage in a research note on Friday, February 28th.
Read Our Latest Analysis on FA
Institutional Inflows and Outflows
First Advantage Trading Down 3.2 %
NYSE:FA opened at $13.51 on Wednesday. First Advantage has a 52 week low of $12.55 and a 52 week high of $20.79. The company has a quick ratio of 3.85, a current ratio of 3.85 and a debt-to-equity ratio of 0.61. The company has a market cap of $2.34 billion, a PE ratio of 450.33 and a beta of 1.21. The business’s 50 day moving average is $17.09 and its two-hundred day moving average is $18.32.
First Advantage Company Profile
First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.
Featured Stories
- Five stocks we like better than First Advantage
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Energy and Oil Stocks Explained
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for First Advantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Advantage and related companies with MarketBeat.com's FREE daily email newsletter.